Xenon Pharmaceuticals (XENE) Announces Proposed Public Offering of Common Shares
Tweet Send to a Friend
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced that it has commenced an underwritten public ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE